Login to Your Account



Financings Roundup


Thursday, November 29, 2012

• NanoBio Corp., of Ann Arbor, Mich., closed an $11 million Series C financing, including full participation from its existing investor syndicate. Proceeds will be used to advance the firm's development programs for herpes labialis, cystic fibrosis and nanoemulsion-based vaccines for respiratory syncytial virus and genital herpes.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription